Risk of early mortality after placement of a temporary-permanent pacemaker

- Temporary-permanent pacemakers [TPPM] are externally placed permanent generators attached to active fixation transvenous leads. Use of TPPM generally includes use of an active fixation lead designed for implantation with a permanent pacemaker.
- TPPM can be used as an alternative to standard temporary pacing leads when placement of a permanent pacemaker is contraindicated.
- We examined the incidence and risk factors for early (within 6 months) mortality after placement of a TPPM.
- Our results show that TPPM placement is a safe procedure with rare direct complications and that CKD and smoking are predictive of increased risk for early mortality in patients undergoing TPPM placement.

BackgroundTemporary-permanent pacemakers [TPPM] are externally placed permanent generators attached to active fixation transvenous leads. TPPM can be used as an alternative to standard temporary pacing leads when placement of a permanent pacemaker is contraindicated. We sought to determine the incidence and risk factors for early (within 6 months) mortality after placement of a TPPM.MethodsElectronic medical records were used to extract baseline characteristics for 152 patients from Wake Forest Baptist Medical Center who had a TPPM placed between the years 2007 and 2012. Multivariable adjusted Cox proportional hazard models were used to estimate hazard ratios [HR] and 95% confidence intervals [C]) for baseline characteristics [age, sex, race, hypertension, diabetes, heart failure, coronary artery disease, smoking, dyslipidemia, chronic kidney disease [CKD], and indication for pacemaker] on early mortality.ResultsOf the 152 patients [mean age 68.9 years; 57.2% female; 86.8% white], 45 [29.6%] died within the first 6 months after TPPM placement. No deaths occurred as a direct result of TPPM placement, and only 1 patient experienced documented non-fatal complications. Maximum time to PPM from the date of insertion of TPPM was 336 days. Using a backward multivariable adjusted hazard regression model, independent risk factors for early mortality were pre-existing CKD [HR (95% CI): 2.240 (1.002-5.010) for eGFR 30-59 and 7.645 (3.594-16.263) for eGFR < 30 compared to eGFR > 60] and history of smoking [HR (95% CI): 2.015 (1.099-3.696)]. Surprisingly, dyslipidemia was protective of early mortality [HR (95%CI): 0.470 (0.240-0.924)].ConclusionTPPM placement is a safe procedure with rare direct complications. CKD and smoking are predictive of increased risk for early mortality in patients undergoing TPPM placement.